Jefferies Maintains 'Hold' Rating on Myriad Genetics (MYGN) Post Q1, Estimates Lowered
Go back to Jefferies Maintains 'Hold' Rating on Myriad Genetics (MYGN) Post Q1, Estimates Lowered| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.98 -0.16 (3.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.14 | 52 Week High | $45.34 | |||
| Open | $4.15 | 52 Week Low | $15.92 | |||
| Day High | $4.17 | P/E | 1.71 | |||
| Day Low | $3.94 | EPS | $2.33 | |||
| Volume | 420,705 | |||||
